CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Open-market sale EVP, Commercial sold 30,553 shares at $20.67 ($631,531)
- 4 Planned sale EVP, General Counsel & Sec sold 55,710 shares at $19.63 ($1,093,587)
- 4 Grant or award Director acquired 18,176 shares (grant or award)
- 4 Grant or award Director acquired 18,176 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 20,718 shares (grant or award)
- 4 Grant or award Director acquired 20,718 shares (grant or award)
- 4 Grant or award Director acquired 20,718 shares (grant or award)
- 4 Grant or award Director acquired 20,718 shares (grant or award)
- 4 Grant or award Director acquired 20,718 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 18,176 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 11,967 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 18,446 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 33,518 shares (to pay taxes)
- 4 Shares withheld for taxes CSO/EVP Disc & Trans Research gave up 10,488 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Commercial gave up 18,065 shares (to pay taxes)
Page 11 of 73 · 1,458 filings